Study may help heart failure through the Parachute Ventricular Partitioning Device

April 10, 2014 by Eliza Winston
Zachary Gertz, M.D.

(Medical Xpress)—If you're jumping out of a plane, a parachute is a life-saving device. It turns out the same may be true if your heart is failing.

Zachary Gertz, M.D., of Virginia Commonwealth University's Pauley Heart Center is leading a new study at VCU to monitor the effects of the Parachute Ventricular Partitioning Device, which may help in the treatment of . The trial will evaluate the Parachute device versus optimal medical therapy in approximately 500 patients at up to 65 medical centers, including VCU.

"The Parachute device is an excellent example of invasive therapy that doesn't require ," said Gertz, who is the director of structural heart disease and an assistant professor in the VCU School of Medicine with a specialization in interventional cardiology. "Right now, we are studying the device as part of a large randomized trial to see if it benefits patients."

The Parachute device will be tested on heart attack survivors suffering from heart failure. Heart failure is a common, debilitating and potentially deadly condition. Its symptoms include shortness of breath, persistent coughing or wheezing, fatigue, lack of appetite or nausea, impaired thinking and increased heart rate—all of which can significantly decrease the patient's quality of life.

Heart failure may occur after a heart attack, when the left chamber of the heart becomes enlarged. In addition, the apex of the heart can become more rounded, causing blood to settle in the bottom of the heart.

Over time, the healthy, undamaged part of the heart will become overloaded as it tries to compensate. That difficulty is increased by the heart's damaged muscle tissue, which becomes stiff scar tissue. As a result, the heart is inflexible and can't pump blood effectively.

"After certain large heart attacks, a portion of the heart muscle turns into a scar. That area of the heart does not beat, and blood can pool there and possibly inhibit the proper function of the remaining normal heart," Gertz said. "The Parachute device looks sort of like a basket, and it is designed to partition off the non-functioning heart."

Through a catheter inserted in the femoral artery, the Parachute implant is deployed in the left ventricle to partition the damaged muscle, excluding the non-functional heart segment from the healthy, functional segment to decrease the overall volume of the left ventricle and restore its geometry and function. This minimally invasive procedure is performed in the catheterization laboratory under conscious sedation.

Once it has partitioned off the non-functioning area of the heart, the geometry and function of the heart should improve. This allows the healthy heart tissue to perform more efficiently during each heartbeat. After the 75-minute procedure, patients shouldn't be able to feel the device in their heart and in approximately six months body tissue will cover the Parachute device, making it permanent.

After the study is complete, Gertz and other researchers will have a better understanding of whether the device slows the progression of failure. They will also be able to tell whether it can reduce repeated hospitalizations and mortality while significantly improving patients' quality of life.

Explore further: Heart separation device improves 3 year outcomes in heart failure patients

Related Stories

Heart separation device improves 3 year outcomes in heart failure patients

August 27, 2012
A novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic heart failure, according to research presented at the ESC Congress ...

New human trial shows stem cells are effective for failing hearts

March 31, 2014
Patients with severe ischemic heart disease and heart failure can benefit from a new treatment in which stem cells found in bone marrow are injected directly into the heart muscle, according to research presented at the American ...

Cardiologists define new heart failure symptom: Shortness of breath while bending over

March 18, 2014
UT Southwestern Medical Center cardiologists have defined a novel heart failure symptom in advanced heart failure patients: shortness of breath while bending over, such as when putting on shoes.

Simple changes in ICU can help heart attack patients

April 1, 2014
To improve recovery for heart attack patients, hospitals should maintain normal day and night cycles for those patients during the first few days after the attack, say University of Guelph researchers.

Artificial hearts may help patients survive until transplant

March 27, 2014
The largest single-center study of patients implanted with a total artificial heart finds the device may help patients in severe heart failure survive until they can receive a heart transplant, according to research to be ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.